(Q35012176)

5 August 2017

title

Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients (English)

1 reference

5 August 2017

1 reference

10

Pierre Marquet

0 references

Yannick Le Meur

object named as

Yannick Le Meur

9

0 references

author name string

Khaled Benkali

1

1 reference

5 August 2017

Aurelie Prémaud

2

1 reference

5 August 2017

Nicolas Picard

3

1 reference

5 August 2017

Jean-Philippe Rérolle

4

1 reference

5 August 2017

Olivier Toupance

5

1 reference

5 August 2017

Guillaume Hoizey

6

1 reference

5 August 2017

Alain Turcant

7

1 reference

5 August 2017

Florence Villemain

8

1 reference

5 August 2017

Annick Rousseau

11

1 reference

5 August 2017

language of work or name

1 reference

1 January 2009

1 reference

Clinical Pharmacokinetics

5 August 2017

published in

1 reference

5 August 2017

volume

48

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

805-816

1 reference

Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients

5 August 2017

cites work

1 reference

12 December 2020

Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods

1 reference

12 December 2020

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

1 reference

12 December 2020

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

1 reference

12 December 2020

CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients.

1 reference

12 December 2020

Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients

1 reference

12 December 2020

Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation

1 reference

12 December 2020

Chronopharmacokinetics of tacrolimus in kidney transplant recipients: occurrence of acute rejection

1 reference

12 December 2020

Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies

1 reference

12 December 2020

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

1 reference

12 December 2020

Human P-glycoprotein transports cyclosporin A and FK506.

1 reference

12 December 2020

Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group

1 reference

12 December 2020

Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator

1 reference

12 December 2020

Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.

1 reference

12 December 2020

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients

1 reference

12 December 2020

Clinical pharmacokinetics of tacrolimus

1 reference

12 December 2020

Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients.

1 reference

12 December 2020

Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients

1 reference

12 December 2020

Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients

1 reference

12 December 2020

AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients

1 reference

12 December 2020

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

1 reference

12 December 2020

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

12 December 2020

Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients

1 reference

12 December 2020

Some suggestions for measuring predictive performance

1 reference

12 December 2020

The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants

1 reference

12 December 2020

Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients

1 reference

12 December 2020

Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis.

1 reference

12 December 2020

The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data

1 reference

12 December 2020

Use of the nuclear receptor PXR to predict drug interactions

1 reference

12 December 2020

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

1 reference

12 December 2020

Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements

1 reference

12 December 2020

Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression

1 reference

12 December 2020

10.2165/11318080-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1013396355

0 references

1 reference